ANAPLASTIC LYMPHOMA KINASE C1156Y
UNII 1L250UVH21

Substance Identification & Data

This profile provides standardized clinical and technical data for Anaplastic Lymphoma Kinase C1156y, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1L250UVH21.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
1L250UVH21
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ANAPLASTIC LYMPHOMA KINASE C1156Y
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anaplastic Lymphoma Kinase C1156y. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ALK C1156Y MUTANT
ANAPLASTIC LYMPHOMA KINASE C1156Y

Systematic Nomenclature

ALK TYROSINE KINASE RECEPTOR C1156Y

Technical Codes

CD246 C1156Y
CD-246 C1156Y